Arteriolization of capillaries and FGF-2 upregulation in skeletal muscles of patients with chronic peripheral arterial disease

Microcirculation

Volumn 12, Issue 6, 2005, Pages 527-537

  Baum, Oliver ^a   Djonov, Valentin ^a   Ganster, Murielle ^b   Widmer, Matthias ^b   Baumgartner, Iris ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Arteriolization; Basement membrane; Capillary; Critical limb ischemia (CLI); Fibroblast growth factor (FGF); Peripheral arterial disease

Indexed keywords

ACTIN; COLLAGEN TYPE 4; FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN;

AGE DISTRIBUTION; ARTERIOLIZATION; ARTICLE; BASEMENT MEMBRANE; CAPILLARY; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEG MUSCLE; MICROVASCULARIZATION; MUSCLE ISCHEMIA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER; THICKNESS; UPREGULATION;

AGED; AGED, 80 AND OVER; ARTERIOLES; BASEMENT MEMBRANE; CAPILLARIES; CHRONIC DISEASE; COLLAGEN TYPE IV; ENDOTHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PERIPHERAL VASCULAR DISEASES; UP-REGULATION;

EID: 25144474193     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1080/10739680591003413     Document Type: Article

References (40)

1. Baum O, Da Silva-Azevedo L, Willerding G, Wockel A, Planitzer G, Gossrau R, Pries AR, Zakrzewicz A. (2004). Endothelial NOS is main mediator for shear stress-dependent angiogenesis in skeletal muscle after prazosin administration. Am J Heart Circ Physiol 287:H2300-H2308.
2. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM. (1998). Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97:1114-1123.
3. Branchereau A, Jacobs M, Eds. (1999). Critical Limb Ischemia. Armonk: Futura.
4. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y. (2003). Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9:604-613.
5. Carmeli E, Moas M, Reznick AZ, Coleman R. (2004). Matrix metalloproteinases and skeletal muscle: a brief review. Muscle Nerve 29:191-197.
6. Comerota AJ, Throm RC, Miller KA, Henry T, Chronos N, Laird J, Sequeira R, Kent CK, Bacchetta M, Goldman C, Salenius JP, Schmieder FA, Pilsudski R. (2002). Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial. J Vasc Surg 35:930-936.
7. Conway EM, Collen D, Carmelict P. (2001). Molecular mechanisms of blood vessel growth. Cardiovasc Res 49:507-521.
8. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. (1998). Mouse model of angiogenesis. Am J Pathol 152:1667-1679.
9. Da Silva-Azevedo L, Baum O, Zakrzewicz A, Pries A. (2002). Vascular endothelial growth factor is expressed in endothelial cells isolated from skeletal muscles of nitric oxide synthase knockout mice during prazosin-induced angiogenesis. Biochem Biophys Res Commun 297:1270-1276.
10. Dawson DL, Hagino RT. (2001). Critical limb ischemia. Curr Treat Options Cardiovasc Med 3:237-249.
11. Djonov V, Baum O, Burri P. (2003). Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res 314:107-117.
12. Djonov V, Schmid M, Tschanz SA, Burri PH. (2000). Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ Res 86:286-292.
13. Donnelly R, Yeung JM. (2002). Therapeutic angiogenesis: a step forward in intermittent claudication. Lancet 359:2048-2050.
14. European working group on critical leg ischemia (1991). Second European consensus document on chronic critical leg ischemia. Circulation 84 (Suppl IV):IV1-IV26.
15. Flück M. Gustafsson T. (2003). VEGF protein in human ischemic skeletal muscle. Am J Pathol 163:2636-2637.
16. Gerhardt H, Betsholtz C. (2003). Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314:15-23.
17. Gloe T, Sohn HY, Meininger GA, Pohl U. (2002). Shear stress-induced release of basic fibroblast growth factor from endothelial cells is mediated by matrix interaction via integrin alpha(v)beta3. J Biol Chem 277:23453-23458.
18. Gustafsson T, Kraus WE. (2001). Exercise-induced angiogenesis-related growth aid transcription factors in skeletal muscle, and their modification in muscle pathology. Front Biosci 1:D75-D89.
19. Hansen-Smith F, Egginton S, Zhou AL, Hudlicka O. (2001). Growth of arterioles precedes that of capillaries in stretch-induced angiogenesis in skeletal muscle. Microvasc Res 62:1-14.
20. Helisch A, Schaper W. (2003). Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10:83-97.
21. Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ, Annex BH. (2002). Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359:2053-2058.
22. Lindner V, Reidy MA. (1991). Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 88:3739-3743.
23. Lloyd-Jones DM, Bloch KD. (1996). The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 47:365-375.
24. Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M, Sugimachi K, Sueishi K. (2002). Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res 90:966-973.
25. McMillan DE. (1978). Diabetic angiopathy-its lessons in vascular physiology. Am Heart J 96:401-406.
26. Nehls V, Drenckhahn D. (1991). Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J Cell Biol 113:147-154.
27. Palmer-Kazen U, Wahlberg, E. (2003). Arteriogenesis in peripheral arterial disease. Endothelium 10:225-232.
28. Palmer-Kazen U, Wariaro D, Luo F, Wahlberg E. (2004). Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia. J Vasc Surg 39:621-628.
29. Peirce SM, Skalak TC. (2003). Microvascular remodeling: a complex continuum spanning angiogenesis to arteriogenesis. Microcirculation 10:99-111.
30. Rissanen TT, Vajanto I, Hiltunen MO, Rutanen J, Kettunen MI, Niemi M, Leppanen P, Turunen MP, Markkanen JE, Arve K, Alhava E, Kauppinen RA, Yla-Herttuala S. (2002). Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol 160:1393-1403.
31. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, Gassmann M, Candinas D. (2001). HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15:2445-2453.
32. Sullivan CJ, Doetschman T, Hoying JB. (2002). Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb. J Appl Physiol 93:2009-2017.
33. Tsilibary EC. (2003). Microvascular basement membranes in diabetes mellitus. J Pathol 200:537-546.
34. Tuomisto TT, Rissanen TT, Vajanto I, Korkeela A, Rutanen J, Yla-Herttuala S. (2004). HIF-VEGF-VEGFR-2, TNF-alpha and IGF pathways are up-regulated in critical human skeletal muscle ischemia as studied with DNA array. Atherosclerosis 174:111-120.
35. Van Gieson EJ, Murfee WL, Skalak TC, Price RJ. (2003). Enhanced smooth muscle cell coverage of microvessels exposed to increased hemodynamic stresses in vivo. Circ Res 92:929-936.
36. Vincent KA, Shyu KG, Luo Y, Magner M, Tio RA, Jiang C, Goldberg MA, Akita GY, Gregory RJ, Isner JM. (2000). Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1 alpha/VP16 hybrid transcription factor. Circulation 102:2255-2261.
37. Walgenbach KJ, Gratas C, Shestak KC, Becker D. (1995). Ischaemia-induced expression of bFGF in normal skeletal muscle: a potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle. Nat Med 1:453-459.
38. Wu HM, Yuan Y, McCarthy M, Granger HJ. (1996). Acidic and basic FGFs dilate arterioles of skeletal muscle through a NO-dependent mechanism. Am J Physiol 271:H1087-H1093.
39. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. (2000). Vascular- specific growth factors and blood vessel formation. Nature 407:242-248.
40. Yla-Herttuala S, Alitalo K. (2003). Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 9:694-701.